Researchers from New York City-based NYU Langone Health departed from a trial investigating a tuberculosis vaccine’s potential as a pediatric Type 1 diabetes vaccine, The New York Times reported Jan. 20.
Read the full post on Becker's Hospital Review - Healthcare News
